Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
about
Translating cancer genomes and transcriptomes for precision oncologyAttitudes regarding privacy of genomic information in personalized cancer therapyObtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.The Future of Patient Engagement in the Governance of Shared Data.Understanding patient and provider perceptions and expectations of genomic medicine.Tumor genome analysis includes germline genome: are we ready for surprises?Scenario drafting for early technology assessment of next generation sequencing in clinical oncologyConceptual and terminological confusion around personalised medicine: a coping strategy.Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.Patient knowledge and information-seeking about personalized cancer therapy.Physicians' attitudes about multiplex tumor genomic testing.Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.What's in a word? The person of personalized (nano)medicine.Tumor profiling and the incidentalome: patient decisions and risks.Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.Discussing molecular testing in oncology care: Comparing patient and physician information preferences.Why take part in personalised cancer research? Patients' genetic misconception, genetic responsibility and incomprehension of stratification-an empirical-ethical examination.Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic.Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocolGenetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay.The fuzzy world of precision medicine: deliberations of a precision medicine tumor board.Patient preference: a comparison of electronic patient-completed questionnaires with paper among cancer patients.Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore.A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.Young Adult Female Cancer Survivors' Concerns About Future Children's Health and Genetic Risk.Genomic testing in cancer: patient knowledge, attitudes, and expectations.The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.Differences in attitudes toward genetic testing among the public, patients, and health-care professionals in KoreaAdditional germline findings from a tumor profiling programThe Patient in Precision Medicine: A Systematic Review Examining Evaluations of Patient-Facing Materials
P2860
Q26777081-05068E3B-E32E-41D7-A125-EF4AC5EC9276Q28655533-05973ED6-D804-4312-87C0-3BC9784D6CC4Q30591763-6A6985B8-DFC8-45B2-8C8B-6AEDD96EC9FCQ31089858-328FD2EF-042D-4692-8C3B-184F325B7CD1Q34859653-89D58052-7368-4EBF-842D-40FC6D34D883Q35004182-0670349F-EC4E-49FB-A2BF-92E34F3027DCQ35916535-001CB13A-3A02-404B-85BD-A63792C67DEBQ36080996-FCA4F218-760C-40DD-8770-39319F2F90BFQ36301400-94825229-E1FD-455D-88E0-3A3C1BCE0008Q36682093-5AC0621C-6A6A-4087-9DBD-125A97DA7D7FQ37712065-BFE874B1-AB12-4268-8CA6-B3F385FCA7A0Q37726365-152274B7-404E-4A62-8289-3B490680C874Q38601749-1B0CF0F2-FB7F-4587-93F4-EA17D48BD050Q38631735-6BD81E85-7187-493B-9149-091FB3C254A5Q38719280-CE0CE63C-033D-43BC-A39D-90116FA2DADEQ38763892-1840C83D-E4E3-4C54-9433-507412D1A7D7Q38832807-11106665-2717-4A00-B6C6-D1F2175354C6Q38840660-24741F01-1337-42A9-97A2-254AF9A4B102Q39237394-02FD9846-1621-4973-9A58-56198569BEF2Q40568462-D6BE1B88-4012-4B3F-869F-659E0F6149A6Q40720451-088885D7-C16D-4247-8CE8-F9483D13B87EQ41067511-C34784AB-FEC0-436A-AAB5-F75CFB4F8F21Q44129723-E200ED06-5EF3-4A2D-8BFB-93D663490D6FQ45951380-248804DD-3704-4055-B778-E0430F0DFC5AQ46258028-36B02E13-A035-489B-BA35-8B9A5620DA41Q46652808-23954CC5-86DF-474A-A3CE-AE5435A091D5Q47549500-56EF9DF4-A864-4C41-AB02-CFAE31A069F0Q47755758-D4065076-005E-4CA4-B86C-E4DF3A5E8E0EQ52330740-C37325CC-C60E-4800-949E-4E6ED7156EEEQ55243290-31C23130-24CE-4E84-877A-C7BBD4CC3432Q57212583-9A8A0FF9-A5F6-46AD-A711-B148F75F4DA9Q57640179-B6CE7E46-3AEC-4D59-B80E-9E71AC481489Q58766962-3639A78B-6C76-4CE4-890D-42ED00AD2CD6
P2860
Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Attitudes of patients with can ...... e and somatic genetic testing.
@ast
Attitudes of patients with can ...... e and somatic genetic testing.
@en
type
label
Attitudes of patients with can ...... e and somatic genetic testing.
@ast
Attitudes of patients with can ...... e and somatic genetic testing.
@en
prefLabel
Attitudes of patients with can ...... e and somatic genetic testing.
@ast
Attitudes of patients with can ...... e and somatic genetic testing.
@en
P2093
P2860
P356
P1476
Attitudes of patients with can ...... e and somatic genetic testing.
@en
P2093
Christopher S Lathan
Elyse R Park
Jane C Weeks
Katherine Hicks-Courant
Stacy W Gray
P2860
P304
329-35, 2 p following 335
P356
10.1200/JOP.2012.000626
P407
P577
2012-08-07T00:00:00Z